Showing results (321-330 of 6,284) with videos related to

Sort By:
Pageof 629
Diabetes, Obesity & Metabolism|January 5, 2019
Development of in vitro three-dimensional co-culture system for metabolic syndrome therapeutic agentsSung B Park, Sun Y Lee, Won H Jung, et al.
Diabetes, Obesity & Metabolism|November 12, 2019
Evaluation of a near-infrared light ultrasound system as a non-invasive blood glucose monitoring deviceSvenja Meyhöfer, Britta Wilms, Flavia Ihling, et al.
Diabetes, Obesity & Metabolism|November 12, 2019
Improved glycaemic variability and time in range with dapagliflozin versus gliclazide modified release among adults with type 2 diabetes, evaluated by continuous glucose monitoring: A 12-week randomized controlled trialAndre G D Vianna, Claudio S Lacerda, Luciana M Pechmann, et al.
Diabetes, Obesity & Metabolism|November 20, 2019
The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment: a post hoc analysisRosalie A Scholtes, Daniël H van Raalte, Ricardo Correa-Rotter, et al.
Diabetes, Obesity & Metabolism|November 28, 2017
Effects of an energy-restricted low-carbohydrate, high unsaturated fat/low saturated fat diet versus a high-carbohydrate, low-fat diet in type 2 diabetes: A 2-year randomized clinical trialJeannie Tay, Campbell H Thompson, Natalie D Luscombe-Marsh, et al.
Diabetes, Obesity & Metabolism|December 6, 2017
Plasma proprotein-convertase-subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetesPetra El Khoury, Ronan Roussel, Frederic Fumeron, et al.
Diabetes, Obesity & Metabolism|December 6, 2017
Comparison of glucose-lowering agents after dual therapy failure in type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trialsFrancesco Zaccardi, Nafeesa N Dhalwani, Jolyon Dales, et al.
Diabetes, Obesity & Metabolism|December 6, 2017
Use and effectiveness of a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) in a real-world population with type 2 diabetes: Results from a European, multicentre, retrospective chart review studyHermione Price, Matthias Blüher, Rudolf Prager, et al.
Diabetes, Obesity & Metabolism|December 22, 2017
Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trialRichard E Pratley, Roy Eldor, Annaswamy Raji, et al.
Diabetes, Obesity & Metabolism|November 15, 2017
Acute oral sodium propionate supplementation raises resting energy expenditure and lipid oxidation in fasted humansEdward S Chambers, Claire S Byrne, Karen Aspey, et al.
Pageof 629